Wadekar JB, Sawant RL and Patal UB: Rheumatoid arthritis and herbal drugs: A review. The J Phytopharmacol. 4:311–318. 2015.

Bullock J, Rizvi SAA, Saleh AM, Ahmed SS, Do DP, Ansari RA and Ahmed J: Rheumatoid arthritis: A brief overview of the treatment. Med Princ Pract. 27:501–507. 2018.PubMed/NCBI View Article : Google Scholar

Zhang Q, Liu Q, Lin C, Baima Y, Li H, Gong H and Lin J: The prevalence of rheumatoid arthritis in middle-aged and elderly people living in Naqu City, Tibet, Autonomous Region of China. J Orthop Surg Res. 15(338)2020.PubMed/NCBI View Article : Google Scholar

Nygaard G and Firestein GS: Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol. 16:316–333. 2020.PubMed/NCBI View Article : Google Scholar

Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ and Xu J: Rheumatoid arthritis: Pathological mechanisms and modern pharmacologic therapies. Bone Res. 6(15)2018.PubMed/NCBI View Article : Google Scholar

Conforti A, di Cola I, Pavlych V, Ruscitti P, Berardicurti O, Ursini F, Giacomelli R and Cipriani P: Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev. 20(102735)2021.PubMed/NCBI View Article : Google Scholar

Yu HC and Lu MC: The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis. Tzu Chi Med J. 31:5–10. 2019.PubMed/NCBI View Article : Google Scholar

Scherer HU, Häupl T and Burmester GR: The etiology of rheumatoid arthritis. J Autoimmun. 110(102400)2020.PubMed/NCBI View Article : Google Scholar

Sharma SD, Leung SH and Viatte S: Genetics of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 38(101968)2024.PubMed/NCBI View Article : Google Scholar

Shi J, van de Stadt LA, Levarht EW, Huizinga TW, Hamann D, van Schaardenburg D and Trouw LA: Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann Rheum Dis. 73:780–783. 2014.PubMed/NCBI View Article : Google Scholar

Deane KD, Demoruelle MK, Kelmenson LB, Kuhn KA, Norris JM and Holers VM: Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol. 31:3–18. 2017.PubMed/NCBI View Article : Google Scholar

Gregersen PK, Silver J and Winchester RJ: The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30:1205–1213. 1987.PubMed/NCBI View Article : Google Scholar

Zhang HG, McDermott G, Seyok T, Huang S, Dahal K, L'Yi S, Lea-Bonzel C, Stratton J, Weisenfeld D, Monach P, et al: Identifying shared genetic architecture between rheumatoid arthritis and other conditions: A phenome-wide association study with genetic risk scores. EBioMedicine. 92(104581)2023.PubMed/NCBI View Article : Google Scholar

Sogkas G and Witte T: The link between rheumatic disorders and inborn errors of immunity. EBioMedicine. 90(104501)2023.PubMed/NCBI View Article : Google Scholar

Arnson Y, Shoenfeld Y and Amital H: Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun. 34:J258–J265. 2010.PubMed/NCBI View Article : Google Scholar

Turner S and Cherry N: Rheumatoid arthritis in workers exposed to silica in the pottery industry. Occup Environ Med. 57:443–447. 2000.PubMed/NCBI View Article : Google Scholar

Pattison DJ, Symmons DP, Lunt M, Welch A, Luben R, Bingham SA, Khaw KT, Day NE and Silman AJ: Dietary risk factors for the development of inflammatory polyarthritis: Evidence for a role of high level of red meat consumption. Arthritis Rheum. 50:3804–3812. 2004.PubMed/NCBI View Article : Google Scholar

Gan RW, Demoruelle MK, Deane KD, Weisman MH, Buckner JH, Gregersen PK, Mikuls TR, O'Dell JR, Keating RM, Fingerlin TE, et al: Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis. Ann Rheum Dis. 76:147–152. 2017.PubMed/NCBI View Article : Google Scholar

Kurkó J, Besenyei T, Laki J, Glant TT, Mikecz K and Szekanecz Z: Genetics of rheumatoid arthritis-a comprehensive review. Clin Rev Allergy Immunol. 45:170–179. 2013.PubMed/NCBI View Article : Google Scholar

Laragione T, Harris C, Azizgolshani N, Beeton C, Bongers G and Gulko PS: Magnesium increases numbers of Foxp3+ Treg cells and reduces arthritis severity and joint damage in an IL-10-dependent manner mediated by the intestinal microbiome. EBioMedicine. 92(104603)2023.PubMed/NCBI View Article : Google Scholar

Auréal M, Machuca-Gayet I and Coury F: Rheumatoid arthritis in the view of osteoimmunology. Biomolecules. 11(48)2020.PubMed/NCBI View Article : Google Scholar

Kondo N, Kuroda T and Kobayashi D: Cytokine networks in the pathogenesis of rheumatoid arthritis. Int J Mol Sci. 22(10922)2021.PubMed/NCBI View Article : Google Scholar

Yazici Y and Simsek I: The 2010 ACR/EULAR rheumatoid arthritis classification criteria: How are they performing in the clinic? Rheumatology. 51 (Suppl 6):vi5–vi9. 2012.

Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, et al: American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 63:573–586. 2011.PubMed/NCBI View Article : Google Scholar

Firestein GS and McInnes IB: Immunopathogenesis of rheumatoid arthritis. Immunity. 46:183–196. 2017.PubMed/NCBI View Article : Google Scholar

de la Guardia C, Rangel G, Villarreal A, Goodridge A, Fernández PL and Lleonart R: Development of in-house, indirect ELISAs for the detection of SARS-CoV-2 spike protein-associated serology in COVID-19 patients in Panama. PLoS One. 16(e0257351)2021.PubMed/NCBI View Article : Google Scholar

Govindarajan R, Duraiyan J, Kaliyappan K and Palanisamy M: Microarray and its applications. J Pharm Bioallied Sci. 4 (Suppl 2):S310–S312. 2012.PubMed/NCBI View Article : Google Scholar

Gao Y, Zhang Y and Liu X: Rheumatoid arthritis: Pathogenesis and therapeutic advances. MedComm (2020). 5(e509)2024.PubMed/NCBI View Article : Google Scholar

Villa Mde G, Jiménez-Jorquera C, Haro I, Gomara MJ, Sanmartí R, Fernández-Sánchez C and Mendoza E: Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritis. Biosens Bioelectron. 27:113–118. 2011.PubMed/NCBI View Article : Google Scholar

Fernández-Sánchez C, Pellicer E, Orozco J, Jiménez-Jorquera C, Lechuga LM and Mendoza E: Plasma-activated multi-walled carbon nanotube-polystyrene composite substrates for biosensing. Nanotechnology. 20(335501)2009.PubMed/NCBI View Article : Google Scholar

Šenolt L, Grassi W and Szodoray P: Laboratory biomarkers or imaging in the diagnostics of rheumatoid arthritis? BMC Med. 12(49)2014.PubMed/NCBI View Article : Google Scholar

Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF and Lakos G: Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. J Rheumatol. 34:1658–1663. 2007.PubMed/NCBI

McInnes IB and Schett G: The pathogenesis of rheumatoid arthritis. N Engl J Med. 365:2205–2219. 2011.PubMed/NCBI View Article : Google Scholar

Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD and Tanasescu R: Extra-articular manifestations in rheumatoid arthritis. Maedica (Bucur). 5:286–291. 2010.PubMed/NCBI

Janeway CA Jr, Travers P, Walport M and Shlomchik MJ: B-cell activation by armed helper T cells. In: Immunobiology: The Immune System in Health and Disease. 5th edition. Garland Science, 2001.

Curran AM, Naik P, Giles JT and Darrah E: PAD enzymes in rheumatoid arthritis: Pathogenic effectors and autoimmune targets. Nat Rev Rheumatol. 16:301–315. 2020.PubMed/NCBI View Article : Google Scholar

van Drongelen V and Holoshitz J: HLA-disease associations in rheumatoid arthritis. Rheum Dis Clin North Am. 43:363–376. 2017.PubMed/NCBI View Article : Google Scholar

Kurowska W, Kuca-Warnawin EH, Radzikowska A and Maśliński W: The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis. Cent Eur J Immunol. 42:390–398. 2017.PubMed/NCBI View Article : Google Scholar

Malemud CJ: Matrix metalloproteinases and synovial joint pathology. Prog Mol Biol Transl Sci. 148:305–325. 2017.PubMed/NCBI View Article : Google Scholar

McInnes IB and Schett G: Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 389:2328–2337. 2017.PubMed/NCBI View Article : Google Scholar

Markusse IM, Dirven L, Gerards AH, van Groenendael JH, Ronday HK, Kerstens PJ, Lems WF, Huizinga TW and Allaart CF: Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study. Arthritis Res Ther. 17(232)2015.PubMed/NCBI View Article : Google Scholar

Frauwirth KA and Thompson CB: Activation and inhibition of lymphocytes by costimulation. J Clin Investig. 109:295–299. 2002.PubMed/NCBI View Article : Google Scholar

Chang CK, Chen PK, Chen CC, Chang SH, Chen CH and Chen DY: Increased levels of omega-3 fatty acids and DHA are linked to pain reduction in rheumatoid arthritis patients treated with janus kinase inhibitors. Nutrients. 13(3050)2021.PubMed/NCBI View Article : Google Scholar

Trieb K and Hofstaetter SG: Treatment strategies in surgery for rheumatoid arthritis. Eur J Radiol. 71:204–210. 2009.PubMed/NCBI View Article : Google Scholar

Qureshi O and Dua A: COX Inhibitors. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL, 2019.

Coutinho AE and Chapman KE: The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 335:2–13. 2011.PubMed/NCBI View Article : Google Scholar

Bywall KS, Kihlbom U, Hansson M, Falahee M, Raza K, Baecklund E and Veldwijk J: Patient preferences on rheumatoid arthritis second-line treatment: A discrete choice experiment of Swedish patients. Arthritis Res Ther. 22(288)2020.PubMed/NCBI View Article : Google Scholar

Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, Carandang K, Deane KD, Genovese M, Huston KK, Kerr G, et al: 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 73:1108–1123. 2021.PubMed/NCBI View Article : Google Scholar

Kartnig F, Bonelli M, Goldmann U, Mészáros N, Krall N, Aletaha D, Heinz LX and Superti-Furga G: Ex vivo imaging-based high content phenotyping of patients with rheumatoid arthritis. EBioMedicine,. 111(105522)2025.PubMed/NCBI View Article : Google Scholar

He M, Hu Z and Yang M: Effects of total glucosides of paeony on serum inflammatory cytokines in animal models of rheumatoid arthritis: A systematic review and meta-analysis. Front Pharmacol. 15(1349259)2024.PubMed/NCBI View Article : Google Scholar

Nalwa HS, Prasad P, Ganguly NK, Chaturvedi V and Mittal SA: Methotrexate intolerance in rheumatoid arthritis. Transl med commun. 8(10)2023.

Takeuchi T, Tatsuki Y, Nogami Y, Ishiguro N, Tanaka Y, Yamanaka H, Kamatani N, Harigai M, Ryu J, Inoue K, et al: Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis. 67:189–194. 2008.PubMed/NCBI View Article : Google Scholar

Deane KD: Can rheumatoid arthritis be prevented? Best Pract Res Clin Rheumatol. 27:467–485. 2013.PubMed/NCBI View Article : Google Scholar

Burmester GR, Feist E and Dörner T: Emerging cell and cytokine targets in rheumatoid arthritis. Nat Rev Rheumatol. 10:77–88. 2014.PubMed/NCBI View Article : Google Scholar

Tanaka Y, Maeshima Y and Yamaoka K: In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritis. Ann Rheum Dis. 71 (Suppl 2):i70–i74. 2012.PubMed/NCBI View Article : Google Scholar

Wu KK: Aspirin and other cyclooxygenase inhibitors: new therapeutic insights. Semin Vasc Med. 3:107–112. 2003.PubMed/NCBI View Article : Google Scholar

Wang F, Sun L, Wang S, Davis JM III, Matteson EL, Murad MH, Luo F and Vassallo R: Efficacy and safety of tofacitinib, baricitinib, and upadacitinib for rheumatoid arthritis: A systematic review and meta-analysis. Mayo Clin Proc. 95:1404–1419. 2020.PubMed/NCBI View Article : Google Scholar

Al Maashari R and Hamodat MM: Methotrexate-induced panniculitis in a patient with rheumatoid arthritis. Acta Dermatovenerol Alp Pannonica Adriat. 25:79–81. 2016.PubMed/NCBI View Article : Google Scholar

Volin MV, Campbell PL, Connors MA, Woodruff DC and Koch AE: The effect of sulfasalazine on rheumatoid arthritic synovial tissue chemokine production. Exp Mol Pathol. 73:84–92. 2002.PubMed/NCBI View Article : Google Scholar

Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A and Kim H: A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 9(30)2013.PubMed/NCBI View Article : Google Scholar

Braun J and Kay J: The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis. Expert Opin Drug Saf. 16:289–302. 2017.PubMed/NCBI View Article : Google Scholar

Fox RI, Herrmann ML, Frangou CG, Wahl GM, Morris RE and Kirschbaum BJ: How does leflunomide modulate the immune response in rheumatoid arthritis? BioDrugs. 12:301–315. 1999.PubMed/NCBI View Article : Google Scholar

Cohen S, Genovese MC, Choy E, Perez-Ruiz F, Matsumoto A, Pavelka K, Pablos JL, Rizzo W, Hrycaj P, Zhang N, et al: Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: A randomised, double-blind, phase III equivalence study. Ann Rheum Dis. 76:1679–1687. 2017.PubMed/NCBI View Article : Google Scholar

Dubois EA and Cohen AF: Abatacept. Br J Clin Pharmacol. 68(480)2009.PubMed/NCBI View Article : Google Scholar

Yu A, Amrute JM and Eghtesady P: Review of interleukin-6 and cardiopulmonary bypass-related end-organ injury along with the potential for mitigation with tocilizumab. World J Pediatr Congenit Heart Surg: Oct 25, 2024 (Epub ahead of print).

Melo AT, Campanilho-Marques R and Fonseca JE: Golimumab (anti-TNF monoclonal antibody): Where we stand today. Hum Vaccin Immunother. 17:1586–1598. 2021.PubMed/NCBI View Article : Google Scholar

Hodge JA, Kawabata TT, Krishnaswami S, Clark JD, Telliez JB, Dowty ME, Menon S, Lamba M and Zwillich S: The mechanism of action of tofacitinib-an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 34:318–332. 2016.PubMed/NCBI

Dogra S, Shah S, Sharma A, Chhabra S and Narang T: Emerging role of baricitinib in dermatology practice: All we need to know! Indian Dermatol Online J. 14:153–162. 2023.PubMed/NCBI View Article : Google Scholar

Mohamed MEF, Bhatnagar S, Parmentier JM, Nakasato P and Wung P: Upadacitinib: Mechanism of action, clinical, and translational science. Clin Transl Sci. 17(e13688)2024.PubMed/NCBI View Article : Google Scholar

Tanaka Y: The JAK inhibitors: Do they bring a paradigm shift for the management of rheumatic diseases? Rheumatology (Oxford). 58 (Suppl_1):i1–i3. 2019.PubMed/NCBI View Article : Google Scholar

Chaiamnuay S, Allison JJ and Curtis JR: Risks versus benefits of cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs. Am J Health Syst Pharm. 63:1837–1851. 2006.PubMed/NCBI View Article : Google Scholar

Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 231:232–235. 1971.PubMed/NCBI View Article : Google Scholar

Berkes EA: Anaphylactic and anaphylactoid reactions to aspirin and other NSAIDs. Clin Rev Allergy Immunol. 24:137–147. 2003.PubMed/NCBI View Article : Google Scholar

Benjamin O, Goyal A and Lappin SL: Disease modifying anti-rheumatic drugs (DMARD). In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL, 2018.

Spies CM, Bijlsma JW, Burmester GR and Buttgereit F: Pharmacology of glucocorticoids in rheumatoid arthritis. Curr Opin Pharmacol. 10:302–307. 2010.PubMed/NCBI View Article : Google Scholar

Stahn C, Löwenberg M, Hommes DW and Buttgereit F: Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol. 275:71–78. 2007.PubMed/NCBI View Article : Google Scholar

Kleiman A and Tuckermann JP: Glucocorticoid receptor action in beneficial and side effects of steroid therapy: Lessons from conditional knockout mice. Mol Cell Endocrinol. 275:98–108. 2007.PubMed/NCBI View Article : Google Scholar

Thomas J, Bansback N, Barber C, Wells G and Hazlewood G: Personalized medicine in rheumatoid arthritis: Combining biomarkers and patient preferences to guide therapeutic decisions. Best Pract Res Clin Rheumatol. 36(101812)2022.PubMed/NCBI View Article : Google Scholar

Aletaha D and Smolen J: The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): A review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 23 (5 Suppl 39):S100–S108. 2005.PubMed/NCBI

Hur B, Gupta VK, Huang H, Wright KA, Warrington KJ, Taneja V, Davis JM III and Sung J: Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity. Arthritis Res Ther. 23(164)2021.PubMed/NCBI View Article : Google Scholar

Laborde CM, Castro-Santos P and Díaz-Peña R: Contribution of multiplex immunoassays to rheumatoid arthritis management: From biomarker discovery to personalized medicine. J Pers Med. 10(202)2020.PubMed/NCBI View Article : Google Scholar

Smolen JS, Aletaha D and McInnes IB: Rheumatoid arthritis. Lancet. 388:2023–2038. 2016.PubMed/NCBI View Article : Google Scholar

Isaacs JD, Burmester GR and Combe B: Evolving concepts of pathogenesis and treatment of rheumatoid arthritis: A review. Nat Rev Rheumatol. 18:123–136. 2022.

Asif HM, Akram M, Akhtar N, Ahmed K, Shah SA, Riaz Rehman R and Khan MI: Rheumatoid arthritis: A review article. International Journal of Applied Biology and Pharmaceutical Technology. 2:108–111. 2011.

Arulselvan P, Fard MT, Tan WS, Gothai S, Fakurazi S, Norhaizan ME and Kumar SS: Role of antioxidants and natural products in inflammation. Oxid Med Cell Longev. 2016(5276130)2016.PubMed/NCBI View Article : Google Scholar

Tsoupras A, Lordan R and Zabetakis I: Inflammation, not cholesterol, is a cause of chronic disease. Nutrients. 10(604)2018.PubMed/NCBI View Article : Google Scholar

Yahfoufi N, Alsadi N, Jambi M and Matar C: The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients. 10(1618)2018.PubMed/NCBI View Article : Google Scholar

Maione F, Russo R, Khan H and Mascolo N: Medicinal plants with anti-inflammatory activities. Nat Prod Res. 30:1343–1352. 2016.PubMed/NCBI View Article : Google Scholar

Dash GK, Suresh P, Sahu SK, Kar DM, Ganapaty S and Panda SB: Evaluation of evolvulus alsinoides Linn for anthelmintic and antimicrobial activities, 2002.

Das B, Choudhury MD, Dey A, Talukdar AD, Nongalleima KH and Deb L: Antioxidant and anti-inflammatory activity of aqueous and methanolic extracts of rhizome part of Drynaria quercifolia (L.). Int J Pharm Pharm Sci. 6:43–49. 2014.

Sani SA, Faik AM, Abdulla R and Kunasekaran S: Phytochemical, antioxidant and antibacterial activities of two kinds of Sabah Zingberaceae. J Phys Conf Ser. 1358(012012)2019.

Obiștioiu D, Hulea A, Cocan I, Alexa E, Negrea M, Popescu I, Herman V, Imbrea IM, Heghedus-Mindru G, Suleiman MA, et al: Boswellia essential oil: Natural antioxidant as an effective antimicrobial and anti-inflammatory agent. Antioxidants (Basel). 12(1807)2023.PubMed/NCBI View Article : Google Scholar

Abdollahi E, Johnston TP, Ghaneifar Z, Vahedi P, Goleij P, Azhdari S and Moghaddam AS: Immunomodulatory therapeutic effects of curcumin on M1/M2 macrophage polarization in inflammatory diseases. Curr Mol Pharmacol. 16:2–14. 2023.PubMed/NCBI View Article : Google Scholar

Deng T, Xu J, Wang Q, Wang X, Jiao Y, Cao X and Xiao C: Immunomodulatory effects of curcumin on macrophage polarization in rheumatoid arthritis. Front Pharmacol. 15(1369337)2024.PubMed/NCBI View Article : Google Scholar

Rahimi VB, Askari VR and Baeeri M: Boswellia species in the treatment of rheumatoid arthritis: Mechanisms and clinical evidence. J Ethnopharmacol. 312(116509, 202)2023.

Wang C, Li D, Zhang J and Yang Y: Tripterygium wilfordii in the treatment of rheumatoid arthritis: A meta-analysis of randomized controlled trials. J Ethnopharmacol. 268(113573)2021.

Liu Q, Chen T, Hu Y and Zhang L: Triptolide suppresses Th17 cell differentiation and promotes regulatory T-cell induction via NF-κB inhibition in rheumatoid arthritis. Front Immunol. 14(1045678)2023.

Wei K, Korsunsky I and Marshall JL: Single-cell transcriptomics identifies fibroblast-like synoviocytes as key therapeutic targets in rheumatoid arthritis. Nature Med. 29:482–493. 2023.

Smolen JS, Aletaha D and McInnes IB: Biomarker-driven precision medicine in rheumatoid arthritis: Challenges and future directions. Lancet Rheumatol. 5:e285–e295. 2023.

Chen Y, Wu H and Zhang Y: AI-driven drug discovery for autoimmune diseases: Applications in rheumatoid arthritis. Front Pharmacol. 15(1204897)2024.

Georgewill UO and Georgewill OA: Antiarthritic activity of Abrus precatorius in Albino rats. J Pharm Allied Sci. 6:2009.

Lee JH, Jung HS, Giang PM, Jin X, Lee S, Son PT and Lee JJ: Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera. J Pharmacol Exp Ther. 316:271–278. 2006.PubMed/NCBI View Article : Google Scholar

Manga HM, Brkic D, Marie DE and Quetin-Leclercq J: In vivo anti-inflammatory activity of Alchornea cordifolia (Schumach. & Thonn.) Müll. Arg.(Euphorbiaceae). J Ethnopharmacol. 92:209–214. 2004.PubMed/NCBI View Article : Google Scholar

Jagadeesh K, Srinivas K and Revankar SP: Anti inflammatory effect of Azadirachta Indica (Neem) in albino rats: An experimental study. IOSR J Pharm. 4:34–38. 2014.

Mengi SA and Deshpande SG: Evaluation of ocular anti-inflammatory activity of Butea frondosa. Indian J Pharmacol. 27(116)1995.PubMed/NCBI View Article : Google Scholar

Sharma A, Bhatia S, Kharya MD, Gajbhiye V, Ganesh N, Namdeo AG and Mahadik KR: Anti-inflammatory and analgesic activity of different fractions of Boswellia serrata. Int J Phytomed. 2:94–99. 2010.

Küpeli E and Yesilada E: Flavonoids with anti-inflammatory and antinociceptive activity from Cistus laurifolius L. leaves through bioassay-guided procedures. J Ethnopharmacol. 112:524–530. 2007.PubMed/NCBI View Article : Google Scholar

Chatterjee GK and Pal SD: Antiinflammatory agents from Indian medicinal plants. Indian Drugs. 21(431)1984.

Paval J, Kaitheri SK, Potu BK, Govindan S, Kumar RS, Narayanan SN and Moorkoth S: Anti-arthritic potential of the plant Justicia gendarussa Burm F. Clinics (Sao Paulo). 64:357–362. 2009.PubMed/NCBI View Article : Google Scholar

Esmat A, Al-Abbasi FA, Algandaby MM, Moussa AY, Labib RM, Ayoub NA and Abdel-Naim AB: Anti-inflammatory activity of Pistacia khinjuk in different experimental models: isolation and characterization of its flavonoids and galloylated sugars. J Med Food. 15:278–287. 2012.PubMed/NCBI View Article : Google Scholar

Olukoga A and Donaldson D: Liquorice and its health implications. J R Soc Promot Health. 120:83–89. 2000.PubMed/NCBI View Article : Google Scholar

Ekambaram S, Perumal SS and Subramanian V: Evaluation of antiarthritic activity of Strychnos potatorum Linn seeds in Freund's adjuvant induced arthritic rat model. BMC Complement Altern Med. 10(56)2010.PubMed/NCBI View Article : Google Scholar

Abudoleh S, Disi A, Qunaibi E and Aburjai T: Anti-arthritic activity of the methanolic leaf extract of Urtica pilulifera L. on albino rats. Am J Pharmacol Toxicol. 6:27–32. 2011.

Diggle PK, Meixner MA, Carroll AB and Aschwanden CF: Barriers to sexual reproduction in Polygonum viviparum: A comparative developmental analysis of P. viviparum and P. bistortoides. Ann Bot. 89:145–156. 2002.PubMed/NCBI View Article : Google Scholar

Marri Praveen MP and Janarthan M: Evaluation of anti arthritic activity of aqueous extract of Hibiscus platinifolius in albino rats. IJRPB. 2013:815–818. 2013.

Hemlatha K and Satyanarayana D: Anti-inflammatory activity of Annona squamosa Linn. Biomed Pharmacol J. 2:17–20. 2015.

Dragos D, Gilca M, Gaman L, Vlad A, Iosif L, Stoian I and Lupescu O: Phytomedicine in joint disorders. Nutrients. 9(70)2017.PubMed/NCBI View Article : Google Scholar

Aziz DZ, Kadhim NJ, Majeed AA and Abood AH: Protective Effects of Ginger extract against Methotrexate induced cytotoxicity in mice. J Phys Conf Ser. 1664(012103)2020.

Xia X, May BH, Zhang AL, Guo X, Lu C, Xue CC and Huang Q: Chinese herbal medicines for rheumatoid arthritis: Text-mining the classical literature for potentially effective natural products. Evid Based Complement Alternat Med. 2020(7531967)2020.PubMed/NCBI View Article : Google Scholar

Ammar NM, Al-Okbi SY and Mohamed DA: Study of the anti-inflammatory activity of some medicinal edible plants growing in Egypt. Med J Islamic World Acad Sci. 10:113–122. 1997.

Amri O, Zekhnini A, Bouhaimi A, Tahrouch S and Hatimi A: Anti-inflammatory activity of methanolic extract from Pistacia atlantica Desf. leaves. Pharmacogn J. 10:71–76. 2018.

Sagnia B, Fedeli D, Casetti R, Montesano C, Falcioni G and Colizzi V: Antioxidant and anti-inflammatory activities of extracts from Cassia alata, Eleusine indica, Eremomastax speciosa, Carica papaya and Polyscias fulva medicinal plants collected in Cameroon. PLoS One. 9(e103999)2014.PubMed/NCBI View Article : Google Scholar

Jäger AK, Hutchings A and van Staden J: Screening of Zulu medicinal plants for prostaglandin-synthesis inhibitors. J Ethnopharmacol. 52:95–100. 1996.PubMed/NCBI View Article : Google Scholar

Oguntibeju OO: Medicinal plants with anti-inflammatory activities from selected countries and regions of Africa. J Inflamm Res. 11:307–317. 2018.PubMed/NCBI View Article : Google Scholar